ICD-10-CM · FY2027New search
Results for “Prophylactic”
Matching codes
Official code-level notes3
- Code first
- any routine childhood examination
- Code also
- , if applicable, encounter for immunization safety counseling (Z71.85)
- Note
- procedure codes are required to identify the types of immunizations given
Official code-level notes3
- Code also
- , if applicable, risk factors for HIV, such as:
- Code also
- contact with and (suspected) exposure to human immunodeficiency virus [HIV] (Z20.6)
- Code also
- high risk sexual behavior (Z72.5-)
Official code-level notes1
- Excludes 2
- long term (current) use of aspirin (Z79.82)
Z79.3Long term (current) use of hormonal contraceptives
Billable / specificOfficial code-level notes1
- Inclusion terms
- Long term (current) use of birth control pill or patch
Official code-level notes3
- Excludes 2
- long-term (current) use of injectable non-insulin antidiabetic drugs (Z79.85)
- Excludes 2
- long term (current) use of oral antidiabetic drugs (Z79.84)
- Excludes 2
- long term (current) use of oral hypoglycemic drugs (Z79.84)
Official code-level notes4
- Inclusion terms
- Long term (current) use of apremilast
- Inclusion terms
- Long term (current) use of immunomodulatory imide drug
- Inclusion terms
- Long term (current) use of lenalidomide
- Inclusion terms
- Long term (current) use of pomalidomide
Official code-level notes4
- Inclusion terms
- Long term (current) use of adalimumab
- Inclusion terms
- Long term (current) use of etanercept
- Inclusion terms
- Long term (current) use of infliximab
- Inclusion terms
- Long term (current) use of monoclonal antibodies
Z79.621Long term (current) use of calcineurin inhibitor
Billable / specificOfficial code-level notes2
- Inclusion terms
- Long term (current) use of cyclosporine
- Inclusion terms
- Long term (current) use of tacrolimus
Official code-level notes1
- Inclusion terms
- Long term (current) use of tofacitinib
Official code-level notes1
- Inclusion terms
- Long term (current) use of sirolimus
Official code-level notes3
- Inclusion terms
- Long term (current) use of azathioprine
- Inclusion terms
- Long term (current) use of mycophenolate
- Inclusion terms
- Long term (current) use of purine synthesis (IMDH) inhibitors
Official code-level notes3
- Inclusion terms
- Long term (current) use of chlorambucil
- Inclusion terms
- Long term (current) use of cisplatin
- Inclusion terms
- Long term (current) use of cyclophosphamide
Official code-level notes4
- Inclusion terms
- Long term (current) use of 5-fluorouracil
- Inclusion terms
- Long term (current) use of 6-mercaptopurine
- Inclusion terms
- Long term (current) use of cytarabine
- Inclusion terms
- Long term (current) use of methotrexate
Official code-level notes3
- Inclusion terms
- Long term (current) use of bleomycin
- Inclusion terms
- Long term (current) use of doxorubicin
- Inclusion terms
- Long term (current) use of mitomycin C
Official code-level notes4
- Inclusion terms
- Long term (current) use of paclitaxel
- Inclusion terms
- Long term (current) use of plant alkaloids
- Inclusion terms
- Long term (current) use of vinblastine
- Inclusion terms
- Long term (current) use of vincristine
Official code-level notes3
- Inclusion terms
- Long term (current) use of etoposide
- Inclusion terms
- Long term (current) use of irinotecan
- Inclusion terms
- Long term (current) use of topotecan